August 30, 2022 - AB Science announces filing of marketing authorization application for Alsitek in the treatment of amyotrophic lateral sclerosis (ALS) and its validation by the European Medicines Agency (EMA))
Submitted by adminlouis on Tue, 08/30/2022 - 09:05
